D
Revolution Medicines, Inc. RVMD
$37.01 $0.531.45% NASDAQ
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

06/30/2025 03/31/2025 12/31/2024 09/30/2024 06/30/2024
Net Income -85.98% -83.97% -20.45% -44.13% -35.54%
Total Depreciation and Amortization 38.70% 38.69% 20.68% 39.67% 65.10%
Total Amortization of Deferred Charges 0.00% 0.00% 0.00% 0.00% 0.00%
Total Other Non-Cash Items 278.53% 12,088.79% -35.90% 48.47% -13.78%
Change in Net Operating Assets 9.22% 105.16% 98.62% 478.72% -122.28%
Cash from Operations -73.02% -21.10% -14.70% -29.77% -90.95%
Capital Expenditure -210.55% -3.13% 47.26% -38.86% -114.39%
Sale of Property, Plant, and Equipment -- -- -- -- --
Cash Acquisitions -- -- -- -- --
Divestitures -- -- -- -- --
Other Investing Activities -62.19% 94.82% -3.60% -122.47% 360.09%
Cash from Investing -68.25% 93.57% -3.29% -127.75% 347.90%
Total Debt Issued -- -- -- -- --
Total Debt Repaid -- -- -- -- --
Issuance of Common Stock -12.30% 10.12% 30,461.63% 7,545.30% -88.39%
Repurchase of Common Stock -- -- -- -- --
Issuance of Preferred Stock -- -- -- -- --
Repurchase of Preferred Stock -- -- -- -- --
Total Dividends Paid -- -- -- -- --
Other Financing Activities -- -- -88.62% -- --
Cash from Financing 3,319.28% 7.90% 4.10% 7,545.30% -88.39%
Foreign Exchange rate Adjustments -- -- -- -- --
Miscellaneous Cash Flow Adjustments -- -- -- -- --
Net Change in Cash 643.30% 48.61% 1.25% -237.01% 72.37%